Company content about Abzu.
Explore the official endeavors and initiatives of Abzu.
Select your favorite media.
Or simply browse all official company content about Abzu.
Abzu is proud to announce its participation in the ELEGANT NORTH project, contributing with expertise in artificial intelligence and bioinformatics to develop cutting-edge algorithms for analyzing complex genetic data, with a focus on improving patient outcomes.
Former CTO Victor Galindo steps up as CEO to propel Abzu's vision of explainable AI.
Casper joins EU-Startups podcast not only to talk about the benefits, but also the real challenges of startups building their tech stacks on black-box AI infrastructure, and the issue of uncertainty over upcoming regulations from the EU and other regulatory bodies.
Code camp is a tradition that we hold close to our hearts, not just because we've been doing it for over 5 years, but because it's a very efficient and effective way for us to create and innovate.
Christian Lund, co-founder of Templafy, joins the board of directors at Abzu, the Danish-Spanish startup that builds and applies trustworthy AI to tackle complex challenges for the world’s leading companies.
Casper Wilstrup, a global expert in explainable, trustworthy AI, shares his Top Five Tips For Harnessing AI Technology to Propel People Operations.
Abzu, the Danish/Spanish startup that builds trustworthy AI to tackle complex challenges for the world's leading companies., welcomes Kasper Sommer as its new Chief Financial Officer.
Abzu, the Danish-Spanish startup that builds and applies trustworthy AI to tackle complex challenges for the world’s leading companies, secures ISO 27001:2022 certification, reinforcing its value proposition for explainable, resilient, and safe AI solutions.
Casper Wilstrup, a global expert in explainable, trustworthy AI, tells Jyske Bank TV at Nordic Fintech Week why both the answer and the reasoning behind the answer are important in AI applications.
Scientists at Abzu and NASA GeneLab have identified gene combinations that explain the origin of rashes astronauts develop during space missions
An enlightening conversation with Marco Salvatore , a pioneer in the use of AI and ML in biomarker discovery and drug development.
Abzu, the Danish / Spanish startup that has introduced new methods and technology to drive discoveries and reduce R&D costs for pharmaceutical and biotech companies, is thrilled to win Best HealthTech at the 2023 Nordic Startup Awards.
The application designs RNA therapeutics through parallel hypotheses testing of drug targets and individual antisense oligonucleotide (ASO) drug properties.
Abzu® announced that the United States Patent and Trademark Office (USPTO) has issued Abzu Aps a patent number US 11,537,686 titled “Method of Deriving a Correlation” that protects the technology behind the pioneering QLattice algorithm.
Launched in collaboration with the Ethical AI Governance Group (EAIGG) and the Ethical AI Database (EAIDB), the Nordic Ethical AI Landscape is the only publicly available, vetted database of AI companies in the Nordics that provide ethical services.
To address the deficiency of treatments for rare diseases, the selected partners in project Elegant North will create a cross-border, rare disease data-sharing platform to foster cross-sector collaboration between researchers, companies, and healthcare systems.
Peptomyc used the QLattice and Abzu’s expertise in patient stratification to reveal early predictive response-biomarkers to treatment with OMO-103 in metastatic patients. The analysis by the QLattice was conducted on a very small clinical trial of 22 patients.
On Forward: An interview with Casper Wilstrup for an in-depth intro into Abzu and Abzu's proprietary trustworthy AI technology.
Abzu will be applying the €2.5 million grant to the development of the Abzu AI platform, a user-friendly and easy-to-operate platform built on the QLattice engine that makes interpretable and explainable predictions widely accessible.
We're thrilled to announce that Gartner has named Abzu a "Cool Vendor" in AI for excelling in explainability, fairness, and trustworthiness.
Mette Kirstine Agger will help Abzu strengthen its position in life science and biotech by building a bridge between research and business development with her special experience in how new technologies can create and support growth and business opportunities within biotech and a wide range of other lines of industries.
Abzu om Techtopia: Den kunstige intelligens skal ud af den sorte box, så vi kan forstå, hvordan den er nået til sit resultat, og hvad vi kan bruge det til.
On The Healthtech Podcast, Casper talks about how Abzu was founded, and everything healthcare and technology.
A 2-minute introduction to Abzu, how we apply our AI technology to drug discovery, and our partnership with CataloniaBio and HealthTech.
Basel Area Business & Innovation, a non-profit agency dedicated to helping startups, institutions, and companies find business success in the Basel Area, was integral in supporting Abzu’s settlement and facilitating access to the thriving ecosystem.
Accelerating scientific discoveries with Abzu's explainable AI: A breast cancer example
The two companies aim to have a rapid target screening application available this year, enabling Contera Pharma to advance better nucleic acid-based therapeutics.
Prior to the record-breaking seed round in Denmark of € 5.8 M, Abzu raised a total of € 2.9 M. Abzu plans to accelerate commercialization within pharmaceutical drug discovery and mature its AI platform for application in other industry verticals.
Abzu er de 100 % transparente ift. alt fra økonomi til bestyrelsesmateriale. Det her er deres iværksætterhistorie.
The transparent and explainable graph-based models from Abzu allow Byrd to precisely understand what inputs have been used to determine if content has been falsified.
Abzu’s proprietary innovation completely changes the way problems are solved by introducing a new standard of interpretability. This funding will be used for research and product development.
At Abzu, we’re for human-centric tech. We’re not for control by external agents, so we’ll never ask for anything we don’t need.
“My skepticism towards machine learning is that people apply very complicated models with lots of features to problems that are probably easier to solve. What I like about your product is that it takes into consideration that simpler models could also be a solution,” commented a user.
Copenhagen- and Barcelona-led startup Abzu® is creating a SaaS platform that automatically builds advanced AI solutions, bringing AI to a much broader space of customers.
Subscribe for
notifications from Abzu.
You can opt out at any time. We’re cookieless, and our privacy policy is actually easy to read.
